Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jennifer Wilkie

Physician Assistant Columbia, SC Physician Assistant

NPI 1215582812 CMS profile 11204195

111 Doctor Cir, Columbia, SC 29203

Open in the dashboard

General payments

$8,830

401 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jennifer Wilkie of Columbia, SC is reported in the CMS Open Payments database as having received $8,830 across 401 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,648 147
2024 General $2,711 116
2023 General $1,307 63
2021 General $1,164 75

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Wilkie
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Jennifer Wilkie were reported at $3,648. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Jennifer Wilkie Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,164 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $1,307 $167 $52–$557 $160
2024 $2,711 $178 $55–$600 $164
2025 $3,648 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Lilly USA, LLC $1,104 61 payments
  2. Xeris Pharmaceuticals, Inc. $800 42 payments
  3. Novo Nordisk Inc $684 32 payments
  4. Insulet Corporation $611 20 payments
  5. Sanofi-Aventis U.S. LLC $604 16 payments
  6. Corcept Therapeutics $553 38 payments
  7. Beta Bionics, Inc. $444 12 payments
  8. Recordati_Rare_Diseases_Inc. $362 15 payments
  9. Amgen Inc. $360 17 payments
  10. Dexcom, Inc. $333 6 payments
  11. Other $2,974 142 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,830 401 payments
Products named General payments · program years 2021–2025
  1. MOUNJARO $697 32 payments
  2. Omnipod $611 20 payments
  3. Korlym $553 38 payments
  4. Ozempic $531 25 payments
  5. RECORLEV $513 27 payments
  6. TZIELD $458 10 payments
  7. ISTURISA $346 14 payments
  8. JARDIANCE $313 23 payments
  9. RYBELSUS $295 15 payments
  10. CeQur Simplicity $292 2 payments
  11. Other $6,776 292 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 27 drugs

Part D claims

1,107

Median for Physician Assistant: 241

Drug cost

$731,956

Median for Physician Assistant: $4,110

Branded share of claims

66.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mounjaro Tirzepatide Brand 238 $329,569
Jardiance Empagliflozin Brand 74 $95,158
Ozempic Semaglutide Brand 51 $83,723
Farxiga Dapagliflozin Propanediol Brand 54 $57,325
Tresiba Flextouch U-200 Insulin Degludec Brand 39 $44,841
Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog Brand 23 $29,406
Trulicity Dulaglutide Brand 18 $29,292
Rybelsus Semaglutide Brand 14 $20,117
Toujeo Solostar Insulin Glargine,hum.Rec.Anlog Brand 12 $9,501
Tirosint Levothyroxine Sodium Brand 15 $5,846

The 10 drugs with the highest cost, of 27 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 15 billing codes

Paid by Medicare

$3,004

Medicare's payments for the services billed

Medicare patients

27

Average age 74

Services billed

43

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 67%
Arthritis 56%
Chronic kidney disease 52%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 29 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
MOUNJARO
  • Lilly USA, LLC $274
$274 238 —
RECORLEV
  • Xeris Pharmaceuticals, Inc. $214
$214 — —
Korlym
  • Corcept Therapeutics $204
$204 — —
TZIELD
  • SANOFI-AVENTIS U.S. LLC $185
$185 — —
LEQVIO
  • Novartis Pharmaceuticals Corporation $153
$153 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 29 with Patron

Records

401 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record